Regeneron Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for the PD-1 inhibitor Libtayo (cemiplimab-rwlc) as an adjuvant treatment for adult patients with ...

Klifo, an independent provider of Clinical Trial Supply (CTS) packaging and distribution services, has received official Manufacturing and Importation Authorisation from the Danish Medicines Agency ...

Molcure has entered into a multi-year strategic research agreement with Boehringer Ingelheim for the discovery of innovative ...

Elix and the Graduate School of Life Sciences at Tohoku University have signed a joint research agreement aimed at advancing ...

Adze Biotechnology, a preclinical-stage company developing systemically deliverable oncolytic immunotherapies, is ...

CAR-T cell therapy has demonstrated remarkable success in treating hematologic malignancies and is now expanding into solid tumors. On June 1, 2025, The Lancet published positive results from the ...